Determining the effect of Rosa canina capsules on the incidence of urinary tract infection in the puerperium

Determining the effect of Rosa canina capsules on the incidence of urinary tract infection in the puerperium: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016040910324N30

Enrollment

400

Registered

2016-08-28

Start date

2016-09-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract infection following delivery. Urinary tract infection following delivery

Interventions

Intervention 1: The intervention group will receive two capsules of 500 mg Rosa canina daily ½ hours after two meals (breakfast and dinner) orally with a full glass of water for 18 days. Intervention

Treatment - Drugs

Placebo

The intervention group will receive two capsules of 500 mg Rosa canina daily ½ hours after two meals (breakfast and dinner) orally with a full glass of water for 18 days.

The intervention group will receive two capsules of 500 mg placebo (containing starch) daily ½ hours after two meals (breakfast and dinner) orally with a full glass of water for 18 days.

Eligibility

Sex/Gender

Female

Age

15 Years to 49 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having a cesarean section in the last 48 hours; Taking of three doses of antibiotics after surgery; Having willingness to participate in the study; Having phone number for follow-up; Not participate in other similar studies. Exclusion criteria: Having symptoms of urinary tract infections; Specific conditions that need to take antibiotics after discharge; Using of immunosuppressive drugs and related drugs to the respiratory system; Lack of catheterization during cesarean section

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The incidence of urinary tract infection (UTI). Timepoint: 7-10 and 20 days after cesarean section. Method of measurement: Urine culture and checklist of urinary infection symptoms.	—

Secondary

Measure	Time frame
Side events. Timepoint: During the study. Method of measurement: Checklist of side events.;The incidence of pyelonephritis. Timepoint: During 20 days after cesarean. Method of measurement: Urine culture and checklist of urinary infection symptoms.;The incidence of cystitis. Timepoint: During 20 days after cesarean. Method of measurement: Urine culture and checklist of urinary infection symptoms.;The incidence of asymptomatic bacteriuria. Timepoint: 7-10 days and 20 days after cesarean. Method of measurement: Urine culture.	—

Measure

Time frame

Side events. Timepoint: During the study. Method of measurement: Checklist of side events.;The incidence of pyelonephritis. Timepoint: During 20 days after cesarean. Method of measurement: Urine culture and checklist of urinary infection symptoms.;The incidence of cystitis. Timepoint: During 20 days after cesarean. Method of measurement: Urine culture and checklist of urinary infection symptoms.;The incidence of asymptomatic bacteriuria. Timepoint: 7-10 days and 20 days after cesarean. Method of measurement: Urine culture.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdieh Seifi

Faculty of Nursing & Midwifery, Tabriz University of Medical Sciences

seifimah@gmail.com+98 41 4422 1874

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026